Quantum BioPharma Ltd. Share Premium
Quantum BioPharma Ltd. (QNTM) had Share Premium of $35.41 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-03-26
- 2019-12-31: Share Premium 23.09M CAD.
- 2018-12-31: Share Premium 4.98M CAD.
CAD
| Period end | Share Premium |
|---|---|
| 2019-12-31 | 23.09M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 4.98M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Share Premium |
|---|---|
| 2025-12-31 | $35.41M 20-F · filed 2026-03-26 |
| 2025-09-30 | $33.58M 6-K · filed 2025-11-06 |
| 2025-06-30 | $32.58M 6-K · filed 2025-08-07 |
| 2025-03-31 | $31.96M 6-K/A · filed 2025-06-16 |
| 2024-12-31 | $31.07M 20-F · filed 2026-03-26 |
| 2024-09-30 | $31.13M 6-K · filed 2024-11-12 |
| 2024-06-30 | $30.66M 6-K/A · filed 2024-08-19 |
| 2023-12-31 | $30.23M 20-F/A · filed 2025-03-31 |
| 2022-12-31 | $28.50M 20-F · filed 2024-04-02 |
| 2021-12-31 | $22.58M 20-F · filed 2023-03-31 |
| 2020-12-31 | $18.79M 20-F · filed 2022-03-31 |
| 2019-12-31 | $17.37M 40-F · filed 2021-03-17 |
| 2019-01-01 | $3.74M 40-F · filed 2021-03-17 |
| 2018-12-31 | $3.74M 40-F · filed 2021-03-17 |